NCT03720353View on ClinicalTrials.gov

Pharmacological Intervention for Symptomatic Snoring

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

December 17, 2018

Primary Completion Date

December 10, 2019

Study Completion Date

December 10, 2019

Conditions
Snoring
Interventions
DRUG

SAS2094AH and SAS2094BH

SAS2094AH and SAS2094BH for 7 days, preceded by SAS2094AL and SAS2094BH for 3 days.

DRUG

SAS2094AL and SAS2094BL

SAS2094AL and SAS2094BL for 10 days

DRUG

Placebo

Placebo for 10 days. Capsules will mimic active treatments.

Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

All Listed Sponsors
lead

Brigham and Women's Hospital

OTHER

NCT03720353 - Pharmacological Intervention for Symptomatic Snoring | Biotech Hunter | Biotech Hunter